2506 — Xunfei Healthcare Technology Co Income Statement
0.000.00%
- HK$9.72bn
- HK$9.52bn
- CNY733.98m
Annual income statement for Xunfei Healthcare Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 372 | 472 | 556 | 734 |
| Cost of Revenue | ||||
| Gross Profit | 188 | 231 | 315 | 404 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 481 | 715 | 742 | 900 |
| Operating Profit | -108 | -244 | -186 | -166 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -111 | -244 | -187 | -172 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -89.4 | -209 | -154 | -138 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -83.7 | -189 | -145 | -133 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -83.7 | -189 | -145 | -133 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.658 | -1.56 | -1.18 | -0.891 |